首页> 外国专利> Process for producing mature in vitro dendritic cells, method for producing a vaccine to induce a cellular immune response in a human or animal body, vaccine and specifically configured high molecular weight double stranded polymer

Process for producing mature in vitro dendritic cells, method for producing a vaccine to induce a cellular immune response in a human or animal body, vaccine and specifically configured high molecular weight double stranded polymer

机译:产生成熟的体外树突状细胞的方法,产生在人或动物体内诱导细胞免疫应答的疫苗的方法,疫苗以及特别配置的高分子量双链聚合物

摘要

"PROCESS FOR PRODUCING MATURE DENTRIC CELLS IN VITRO, METHOD FOR PRODUCING A VACCINE FOR INDUCING A CELL IMMUNE RESPONSE IN A HUMAN OR ANIMAL BODY, VACCINE AND POLYMER DOUBLE TAPE RNA WITH A SPECIFICALLY SPECIFICALLY DIFFICULATED WEIGHT. The invention provides a method for producing mature in vitro dendritic cells, which comprises the step of culturing immature dendritic cells in the presence of a specifically configured high molecular weight double stranded RNA (dsRNA) polymer. The specifically configured high molecular weight dsRNA polymer is typically selected from the group comprising poly [I]: poly [CxU]; poly [I]: poly [GxU]; poly [A]: poly [UxC]; poly [A]: poly [UxG] poly [U]: poly [AxC]: poly [U]: poly [IxU]; poly [C]: poly [GxA]; poly [C]: poly [GxU]; poly [G] -pollu [CXA]; poly [G]: poly [CxU] and Ampligen, where x is a proportion of a number from 3 to 40. Immature dendritic cells can be exposed to an antigen before it is matured, and a vaccine including mature dendritic cells showing Antigen can then be prepared. A method for treating cancer, a virus, a parasite and a microorganism is also described.
机译:“用于体外生产成熟齿状细胞的方法,用于产生疫苗的方法,所述疫苗用于在人或动物体,疫苗和聚合物双胶条RNA中诱导细胞免疫反应,并具有特定地特定的差异化的重量,该方法为成熟的体重提供了一种方法,本发明提供了一种成熟的方法。体外树突状细胞,包括在存在特定结构的高分子量双链RNA(dsRNA)聚合物的情况下培养未成熟树突状细胞的步骤,该特定结构的高分子量dsRNA聚合物通常选自包含聚[I]的组:聚[CxU];聚[I]:聚[GxU];聚[A]:聚[UxC];聚[A]:聚[UxG]聚[U]:聚[AxC]:聚[U]: poly [IxU]; poly [C]:poly [GxA]; poly [C]:poly [GxU]; poly [G] -pollu [CXA]; poly [G]:poly [CxU]和Ampligen,其中x为比例从3到40不等。未成熟的树突状细胞可以在抗原成熟之前暴露于抗原,而包含成熟树突状细胞的疫苗则表明可以制备抗原。还描述了用于治疗癌症,病毒,寄生虫和微生物的方法。

著录项

  • 公开/公告号BR0212016A

    专利类型

  • 公开/公告日2004-10-26

    原文格式PDF

  • 申请/专利权人 BIOCLONES (PROPRIETARY) LIMITED;

    申请/专利号BR20020212016

  • 发明设计人 MALCOLM ADAMS;CYRIL DONNINGER;

    申请日2002-08-08

  • 分类号C12N5/06;A61K39/00;C07H21/00;

  • 国家 BR

  • 入库时间 2022-08-21 23:11:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号